ACOR insider filings

Acorda Therapeutics, Inc. — 39 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-06-23. Screen ACOR transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ACOR between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Acorda Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2023-06-234BURNS THOMAS M. — DirectorGrant/award (A): 2,400 (derivative) @ $0EDGAR
2023-06-234Varian John — DirectorGrant/award (A): 1,200 (derivative) @ $0EDGAR
2023-06-234PANEM SANDRA PHD — DirectorGrant/award (A): 1,200 (derivative) @ $0EDGAR
2023-06-234Kelley John P — DirectorGrant/award (A): 1,200 (derivative) @ $0EDGAR
2023-06-234Jensen Peder — DirectorGrant/award (A): 1,200 (derivative) @ $0EDGAR
2023-04-044COHEN RON — President and CEO, DirectorGrant/award (A): 168,800 (derivative) @ $0EDGAR
2023-04-044Clem Kerry M — Chief Commercial OfficerGrant/award (A): 77,300 (derivative) @ $0EDGAR
2023-04-044Belloff Neil S. — General Counsel and Corp SecyGrant/award (A): 77,300 (derivative) @ $0EDGAR
2023-03-204COHEN RON — President and CEO, DirectorPurchase (P): 10,156 @ $0.60 · Purchase (P): 10,000 @ $0.65EDGAR
2023-01-044Varian John — DirectorGrant/award (A): 4,712 (derivative) @ $0EDGAR
2022-09-074Sabella Lauren M — Chief Operating OfficerTax withholding (F): 1,511 @ $0.40EDGAR
2022-09-074Clem Kerry M — Chief Commercial OfficerTax withholding (F): 1,511 @ $0.40EDGAR
2022-06-144Randall Lorin — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2022-06-144PANEM SANDRA PHD — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2022-06-144Kelley John P — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2022-06-144Jensen Peder — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2022-03-214COHEN RON — President and CEO, DirectorSale (S): 2,289 @ $1.70EDGAR
2022-01-044Varian John — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-11-154COHEN RON — President and CEO, DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-11-094Gesser Michael A — Chief Financial OfficerGrant/award (A): 85,000 (derivative) @ $0EDGAR
2021-11-094Belloff Neil S. — General CounselGrant/award (A): 85,000 (derivative) @ $0EDGAR
2021-09-084Sabella Lauren M — Chief Commercial OfficerTax withholding (F): 1,511 @ $4.38EDGAR
2021-09-084Morales Robert — Interim PAO & PFOTax withholding (F): 448 @ $4.38EDGAR
2021-09-084COHEN RON — President and CEO, DirectorTax withholding (F): 3,940 @ $4.38EDGAR
2021-06-044STRADER CATHERINE D. — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-044Randall Lorin — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-044PANEM SANDRA PHD — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-044Kelley John P — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-044Jensen Peder — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-044Greene Barry E — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2021-03-054Sabella Lauren M — Chief Commercial OfficerGrant/award (A): 11,125 @ $0EDGAR
2021-03-054COHEN RON — President and CEO, DirectorGrant/award (A): 29,000 @ $0EDGAR
2021-03-054BLANK BURKHARD — CMO and Head of R&DGrant/award (A): 11,125 @ $0EDGAR
2020-12-034LAWRENCE DAVID — Chief, Bus. Ops & PAOTax withholding (F): 1,141 @ $0.65EDGAR
2020-11-124LAWRENCE DAVID — Chief, Bus. Ops & PAOTax withholding (F): 1,024 @ $0.86EDGAR
2020-09-214Sabella Lauren M — Chief Commercial OfficerGrant/award (A): 3,015 @ $0EDGAR
2020-09-214LAWRENCE DAVID — Chief, Bus. Ops & PAOGrant/award (A): 3,015 @ $0EDGAR
2020-09-214COHEN RON — President and CEO, DirectorGrant/award (A): 8,543 @ $0EDGAR
2020-09-214BLANK BURKHARD — CMO and Head of R&DGrant/award (A): 3,015 @ $0EDGAR

Recent 8-K events — Acorda Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-08-098-K1.03 — Bankruptcy or Receivership
3.03 — Material Modification to Rights of Security Holders
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2024-07-238-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-07-118-K2.01 — Completion of Acquisition or Disposition of Assets
9.01 — Financial Statements and Exhibits
EDGAR
2024-06-258-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-06-128-K8.01 — Other EventsEDGAR
2024-06-048-K8.01 — Other EventsEDGAR
2024-05-248-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-04-268-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-04-178-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
9.01 — Financial Statements and Exhibits
EDGAR
2024-04-048-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ACOR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs